Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized assessor-blind dose-response study of FE 999049 versus GONAL-f in controlled ovarian stimulation for IVF/ICSI
2011-000633-36Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of follitropin delta in female infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Number of oocytes retrieved. Started Aug 2011; status: completed.
02
Drugs
follitropin delta
03
Conditions
female infertility
Beyond the preview
Go deeper on 2011-000633-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000633-36.